United Therapeutics (UTHR) Tops Q2 EPS by $1.07
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $555.91 +1.60%
Revenue Growth %: +1.5%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
CRMT, More
Revenue Growth %: +1.5%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $4.09, $1.07 better than the analyst estimate of $3.02. Revenue for the quarter came in at $446.5 million versus the consensus estimate of $378.75 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Isabella Bank added to Russell 2000 index after Nasdaq listing
- Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
